Search Studies

A Study of the Drug ABBV-383 for Patients with Multiple Myeloma

The purpose of this study is to learn more about the study drug ABBV-383 for patients with multiple myeloma that has returned or has not responded to treatment. We want to find the best dose and learn about the safety and effects of the study drug.

Study Topics

Cancer Cancer: Myeloma

Treating Multiple Myeloma with Study Drug ABBV-383

The purpose of this study is to see how the study drug, ABBV-383, affects patients with multiple myeloma that has returned or been difficult to treat. Some volunteers will get increasing doses of the study drug. We want to see if the increasing doses can reduce a side effect known as cytokine release syndrome.

Study Topics

Cancer Cancer: Myeloma

A Study of the Drug ABBV-383 for Patients with AL Amyloidosis

The purpose of this study is to learn more about the study drug ABBV-383 in patients with amyloidosis. We want to find the best dose and learn about the safety and effects of the study drug.

Study Topics

Cancer Cancer: Leukemia Cancer: Myeloma

Testing the Study Drug Navtemadlin for Patients with Myelofibrosis

This study aims to find out more about using the drug navtemadlin with ruxolitinib. We want to see if these drugs together are safe and helpful for treating myelofibrosis. We also want to know if navtemadlin can help patients who don't improve with just ruxolitinib.

Study Topics

Cancer Cancer: Myeloma